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ABSTRACT
Genetically unstable expanded CAG·CTG trinu-
cleotide repeats are causal in a number of human dis-
orders, including Huntington disease and myotonic
dystrophy type 1. It is still widely assumed that DNA
polymerase slippage during replication plays an im-
portant role in the accumulation of expansions. Nev-
ertheless, somatic mosaicism correlates poorly with
the proliferative capacity of the tissue and rates of
cell turnover, suggesting that expansions can oc-
cur in the absence of replication. We monitored
CAG·CTG repeat instability in transgenic mouse cells
arrested by chemical or genetic manipulation of the
cell cycle and generated unequivocal evidence for
the continuous accumulation of repeat expansions
in non-dividing cells. Importantly, the rates of expan-
sion in non-dividing cells were at least as high as
those of proliferating cells. These data are consistent
with a major role for cell division-independent expan-
sion in generating somatic mosaicism in vivo. Al-
though expansions can accrue in non-dividing cells,
we also show that cell cycle arrest is not sufficient
to drive instability, implicating other factors as the
key regulators of tissue-specific instability. Our data
reveal that de novo expansion events are not lim-
ited to S-phase and further support a cell division-
independent mutational pathway.
INTRODUCTION
At least 17 inherited human neurological disorders are
caused by the expansion of genetically unstable DNA trin-
ucleotide repeats (1,2). Most of these disorders involve a
CAG·CTG repeat expansion, such as Huntington disease
(HD) and myotonic dystrophy type 1 (DM1). Longer in-
herited CAG·CTG repeat alleles cause more severe symp-
toms and an earlier age of onset (2). Expanded alleles are
highly unstable in the germline and show a marked bias
toward additional gains in repeat number, thus account-
ing for the decreasing age of onset and increasing disease
severity in successive generations (anticipation). Expanded
CAG·CTG repeats are also somatically unstable in a pro-
cess that is age-dependent, tissue-specific and expansion-
biased, and mediated by multiple small gains and losses in
repeat number (3,4). In particular, very large expansions ac-
cumulate in the muscle of DM1 patients (5) and in the stria-
tum of HD patients (6), the two major affected tissues in
these disorders. Moreover, higher individual-specific repeat
expansion rates have been directly linked with increased
disease severity and earlier age of onset in HD and DM1
(7,8). These data strongly implicate somatic expansion in
the tissue-specificity and progressive nature of the symp-
toms (2).
Multiple pathways of DNAmetabolism have been impli-
cated in generating repeat expansions in mammalian cells,
such as replication (9–11),mismatch repair (12–16), base ex-
cision repair (17), nucleotide excision repair (18) and tran-
scription (19,20). Most clear is the requirement of func-
tional mismatch repair (MMR) proteins for the accumula-
tion of somatic expansions (12–16). Although it has been
proposed that inappropriate MMR of alternative DNA
structures might operate independently of cell division (14),
MMR is more intimately linked with DNA replication and
it has been suggested thatMMRproteinsmay act instead to
stabilize slipped strand DNA intermediates arising during
replication (21,22). Replication slippage has long been as-
sumed to be an important mechanism for generating expan-
sions (23) and a primary role for DNA replication and cell
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division through DNA polymerase slippage is supported by
data generated in bacteria and yeast model systems (21,24–
25). The replication slippage model predicts that cell divi-
sion is required to generate expansions and that expansions
will accrue at a faster rate in tissues with a high cell turnover.
These predictions are at odds with data derived from HD
and DM1 patients (6,26) and from numerous transgenic
mouse models (27–30) in which there is no obvious cor-
relation between the somatic expansion rate of the DNA
and the proliferative capacity of the tissue. However, such
correlative studies are limited by the complex nature of tis-
sues, which are comprised of multiple cell types with differ-
ing proliferative capacities, and our inability to define the
replicative history of any given cell in vivo. In fact, the ex-
pansion rates of unstable trinucleotide repeats carried by
the same cell type have not been directly compared between
proliferating and non-proliferating cultures. As a result, de-
spite some circumstantial data, no definitive evidence exists
for the continuous accumulation of expansions over time
in homogeneous populations of non-proliferative cells. In-
deed, it has been suggested that DNA replication during
genome duplication and cell division is necessary to initi-
ate expansion in DM1 patient fibroblasts (11).
To explore the role of the cell cycle in mediating expan-
sions, we previously generated a cell culture model that re-
produces time-dependent, expansion-biased tissue-specific
somatic mosaicism (31) derived from a transgenic mouse
model of unstable CAG·CTG repeats (28). Interestingly, the
cell type-specific expansion rates measured in different cul-
tures could not be accounted for by differences in cell di-
vision rates (32). For instance, the repeat tract continued to
expand rapidly in a kidney cell line (D2763K), butwas faith-
fully replicated without mutation for over 100 population
doublings (PDs) in a lung cell line (D2763L). These data
demonstrated that cell division was insufficient to drive ex-
pansion, but did not rule out the possibility that DNA repli-
cation and cell cycle progression were nonetheless required
to mediate expansions. Here we sought to test whether cell
division is absolutely necessary for trinucleotide repeat in-
stability in somatic cells through the establishment of a cell
culture model of replication-independent repeat instability.
The direct comparison of trinucleotide repeat expansion
rates in the same cell type growing under proliferating and
non-proliferating conditions would address this question.
MATERIALS AND METHODS
Mouse cell culture and chemical cell cycle arrest
All experiments were performed in accordance with the
UK Home Office Animals Scientific Procedures Act 1986
and with the guidelines of the host institution for the wel-
fare of animals. Dmt-D transgenic mice carry an expanded
CAG·CTG repeat surrounded by∼750 bp of flankingDNA
from the human DM1 locus (33,34). D2763Kc2 (31) and
D2763L (32) cells were maintained and passaged as previ-
ously described (31,32). For chemical cell cycle arrest exper-
iments, a progenitor culture was split into multiple aliquots:
six no-drug replicate controls and for each cell-cycle in-
hibitor, six replicate treated cultures (Supplementary Fig-
ure S1). All cultures were maintained in parallel throughout
the course of the experiment (up to 121 days) and supplied
with fresh medium every two to three days. Treated cultures
were continuously exposed to the chemicals, with the ex-
ception of mitomycin C (MMC) arrested cells, which were
exposed to 30MMMC for 180minutes, and subsequently
maintained in standardmedium.Dividing control cells were
passaged when confluent, at a 1:40 dilution. Cell viability
was periodically determined by trypan blue exclusion assays
following phosphate buffered saline (PBS) washing, which
eliminated the majority of semi-detached dead cells. Single-
cell clones were obtained by limiting dilution of progenitor
cultures. Cell cycle progression was determined by bromod-
eoxyuridine (BrdU) incorporation assays and proliferating
cell nuclear antigen (PCNA) immunofluorescence (see Sup-
plementary Methods).
p16INK4a and p21WAF1 overexpression and cell cycle arrest
Two progenitor cultures expressing either inducible
p16INK4a or p21WAF1 were split into 12 parallel cultures.
Six proliferating controls were maintained in standard
growth medium in parallel with six cultures continuously
exposed to 10 nM mifepristone A to induce p16INK4a
or p21WAF1 expression. Treated and control cells were
maintained as for the chemical treatment experiments for
89 days following mifepristone A induction. To control for
any effect of pSwitch expression on repeat metabolism, a
pSwitch-transfected progenitor culture was divided into
12 parallel cultures: six no-mifepristone A controls and
six ‘induced’ controls continuously exposed to 10 nM
mifepristone A.
MEF cell culture and cell cycle arrest by serum starvation
Progenitor Dmt-D mouse embryonic fibroblast (MEF) cul-
tures were prepared as previously described (14) and split
into 12 aliquots and cultured to confluence. Six replicate
cultures were arrested by serum starvation in 0.1% (v/v) fe-
tal bovine serum and six dividing control cells were main-
tained in 10% (v/v) fetal bovine serum and passaged when
confluent, at a 1:4 dilution, for up to 139 days.
Protein sample preparation and western blotting
Protein samples were extracted and analyzed as previously
described (14). See Supplementary Methods for detailed
western blot protocols and antibody dilutions.
Small pool PCR amplification
Cell cultures were washed twice with PBS to remove semi-
detached dying/dead cells. Cultured cells were collected by
trypsin digestion and DNA samples were extracted using a
Nucleon DNA extraction kit for blood and tissue culture
(Nucleon) following the manufacturer’s protocol (32). Re-
peat length variability in each sample was assessed by small
pool PCR (SP-PCR) analysis using oligonucleotide primers
DM-C and DM-BR, as previously described (3,31). The
analysis of somaticmosaicism by SP-PCRand the represen-
tation of repeat number variation is described in the Supple-
mentary Methods.
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Statistical analyses
Statistical analyses were performed using Microsoft Excel
and MINITAB for Windows (release 14.1, 2003, Minitab
Inc.).
RESULTS
Chemical arrest of the cell cycle
To develop a non-proliferative cell model of repeat size
instability and to determine directly if DNA replication
and cell division are required to generate trinucleotide re-
peat expansions, we used chemical inhibitors to arrest a
clonal transgenic mouse cell line at various phases of the
cell cycle. The D2763Kc2 cell line was selected to perform
this study because it carries an unstable CAG·CTG repeat
that expands rapidly with time, recreating the step-wise,
expansion-biased somatic instability of trinucleotide repeat
expansions (31). These cells provide a suitable model sys-
tem to investigate the core mechanisms of trinucleotide re-
peat dynamics and identify factors that modify repeat ex-
pansion rates. Cells were arrested in S and G2/M by ex-
posure to MMC (35), in S with hydroxyurea (HU) (36), in
G1 with roscovitine (37), and in G1 and G2 with apicidin
and trichostatin A (TSA) (38,39). For each chemical treat-
ment, six replicate cultures of arrested cells weremaintained
for up to 121 days in parallel with six replicate control cell
cultures (Supplementary Figure S1). To monitor the effect
on cell cycle progression, we carefully examined the num-
ber of viable cells by trypan blue exclusion assays, the lev-
els of DNA synthesis using BrdU incorporation and pro-
tein levels of PCNA (Table 1, Figure 1, Supplementary Fig-
ures S2 and S3). The rapidly proliferating control cells (pop-
ulation doubling time, PDT ∼25 h) expressed high levels
of PCNA in the nucleus and nearly all cells incorporated
high levels of BrdU (94%). The number of viable cells de-
creased significantly following the initial period of expo-
sure to the chemical, as a result of high mortality, and it re-
mained low throughout the treatment. No additional signs
of cell death were detected (e.g. overt cell detachment, cell
membrane breakdown, cell/organelle swelling) as the treat-
ment progressed, hence having minimal impact on the PDT
measured. Viable cells did not accumulate in any treated
cultures and only in HU-treated cultures was there an in-
crease in viable cell numbers at the end of the experimen-
tal period (Figure 1A). All the other chemical treatments
resulted in highly statistically significant reductions in the
rate of incorporation of BrdU (Figure 1B, Supplementary
Figure S2) and dramatic decreases in PCNA protein levels
(Figure 1C, Supplementary Figure S3). In particular, ho-
mogenous nuclear incorporation of BrdU was not detected
in TSA-treated cells and was only observed at very low lev-
els (<2%) in apicidin-treated cells, possibly as a result of a
small fraction of cells that escaped cell cycle arrest. None
of the MMC-treated cells displayed the homogenous nu-
clear incorporation of BrdU typical of the dividing cells,
but a low proportion (∼6%) did present with discrete nu-
clear BrdU-positive intranuclear foci (Figure 2). Such foci
have been observed previously in MMC-treated cells and
shown to be sites of active DNA repair (40). The punctu-
ated cytoplasmic staining in apicidin- and TSA-treated cells
likely results from BrdU incorporation into mitochondrial
DNA (41). Consistent with an S-phase arrest, HU-treated
cells showed only a slight drop in PCNA expression and
BrdU incorporation (91%) following exposure to the chem-
ical for one week. However, HU-treated cultures displayed
a dramatic reduction in cell number after 25 days that only
slowly recovered with time and only exceeded starting cell
numbers at the end of the treatment period (121 days) (Fig-
ure 1A). HU-treated cells thus continued to divide, but with
a dramatically increased PDT of∼120 days. Thus, all of the
chemical treatments resulted in either complete cell cycle ar-
rest, or at least a 100-fold increase in the PDT.
CAG·CTG repeats continue to expand in chemically arrested
cells
The effect of cell cycle arrest on the dynamics of the ex-
panded CAG·CTG repeat was assessed by sensitive SP-
PCR-based approaches (3) to measure repeat length vari-
ation in progenitor cultures, rapidly proliferating controls
cells, solvent controls and chemically arrested cell cultures
(Figure 3A, Supplementary Figure S4). The quantitative
analysis of single molecule SP-PCR products allowed ac-
curate assessment of average repeat sizes before, during and
after chemical treatment. We calculated rates of repeat ex-
pansion by dividing the median increase in repeat size of
each replicate culture by the time in culture (31). The re-
sults revealed that, as expected, the repeat expanded rapidly
in the control proliferating cells, gaining an average of ∼0.5
repeats per day (Figure 3B). The repeat expansion rate was
not altered by DMSO, the solvent used for histone deacety-
lase (HDAC) inhibitors (Table 1). Remarkably, the average
repeat tract length in all six replicates increased relative to
the progenitor culture, throughout the course of the exper-
iment, in all five chemical approaches to cell cycle arrest (P
< 0.02 in each replicate; Mann–Whitney U test; Figure 3,
Supplementary Figure S4). These data demonstrate directly
that expanded CAG·CTG repeat tracts can continue to ex-
pand in the absence of cell division. Notably, with four out
of the five treatments, the rate of expansion per unit of time
was at least as great as observed in the rapidly dividing con-
trol cells (P> 0.05; Mann–WhitneyU test). Indeed, despite
having the least effect on the levels of DNA synthesis and
cell cycle progression, HU was the only treatment to result
in a detectable decrease in the expansion rate relative to the
dividing controls (rates were reduced by ∼15%; P = 0.02;
Mann–Whitney U test). Interestingly, the rate of expansion
inMMC-arrested cells was dramatically increased (>1.2 re-
peats per day; P = 0.005; Mann–Whitney U test).
CAG·CTG repeat size gains in genetically arrested cells
Although the variety of different cellular pathways targeted
by the chemical treatment used argues against it, we consid-
ered it formally possible that the cell division-independent
expansions observed were an artifact of chemical treat-
ments. We therefore sought to establish if the repeat contin-
ued to expand in cells arrested using more physiologically
relevant approaches. D2763Kc2 cells were arrested for up
to 89 days by overexpressing the cyclin-dependent kinase
inhibitors p16INK4a or p21WAF1 (42), using a mifepristone-
inducible gene expression system in six replicate cultures
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Figure 1. Analysis of cell cycle arrest. (A) Cell culture dynamics. The graphs show mean cell survival (±SD) of six replicate cultures over time. Cell survival
of chemically treated cultures, cells expressing p16INK4a and p21WAF1 followingmifepristone A induction, and serum-starvedMEFs, was calculated relative
to the day zero culture. Statistically significant differences between two consecutive time points are illustrated with asterisks (*, P < 0.05; **, P < 0.01;
Mann–WhitneyU test). (B) Proportion of BrdUpositive cells. The histograms show the percentage of BrdU immunopositive cells and the error bars indicate
the 95% confidence intervals for control and treated cultures. Statistically significant reductions in BrdU staining relative to controls are indicated (***, P<
0.001; Fisher’s exact test). (C) Relative PCNA expression levels. The graph on the left shows the quantitative analysis of PCNA protein expression levels in
arrested cells relative to the corresponding proliferating controls. The graph on the right shows the quantitative analysis of PCNAprotein expression (±SD)
in mifepristone A-induced cells, co-transfected with pSwitch regulatory plasmid and pGENE/V5-His A/p16INK4a (p16) or pGENE/V5-His A/p21WAF1
(p21), relative to un-induced transfected controls. Statistically significant reductions in PCNA protein levels relative to proliferating controls are indicated
(*, P < 0.05; Mann–Whitney U test). AU, arbitrary units.
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Figure 2. BrdU incorporation patterns. To measure levels of DNA synthesis we performed a BrdU incorporation assay. Representative low magnification
images (top) reveal the relative proportion of BrdU immunostaining (green) nuclei counter-stained with DAPI (blue). Representative high-magnification
images (bottom) illustrate BrdU immunostaining patterns within individual cells and reveal differences between chemical treatments.
Table 1. Cell culture growth and expanded CAG·CTG repeat dynamics
Treatment [drug
concentration] Time [days] PDs PDT [h]
BrdU
incorporation [%]
(P)a
Median repeat
gain relative to
progenitor
[repeats] (P)b
Median rate of
expansion [repeats
per day] (P)c
Control 1d 121 120 24.2 94 65 (<0.0001) 0.54
Mitomycin C [30
M]e
54 <1 >3000 6 (<0.0001) 68 (<0.0001) 1.26 (0.005)
Apicidin [320 nM
in 0.1% DMSO]
85 <1 >3000 2 (<0.0001) 39 (<0.003) 0.46 (0.066)
Trichostatin A
[160 nM in 0.1%
DMSO]
120 <1 >3000 0 (<0.0001) 68 (<0.0001) 0.56 (0.81)
Hydroxyurea [50
M]
121 ∼1 ∼3000 91 (<0.21) 55 (<0.0001) 0.45 (0.02)
Control 2d 89 100 21.4 94 42 (<0.018) 0.48
DMSO [0.1%] 89 95 22.5 N/D 37 (<0.0004) 0.41 (0.47)
Roscovitine [20
M in 0.1%
DMSO]
89 <1 >3000 26 (<0.0001) 27 (<0.016) 0.33 (0.30)
pSwitch control 89 69 31.0 N/D 45 (<0.0007) 0.50
pSwitch
mifepristone A
[10 nM]
89 68 31.4 97 92 (<0.0001) 1.04 (0.005)
p16 control 89 74 28.9 N/D 46 (<0.032) 0.52 (0.94)
p16 mifepristone
A [10 nM]
89 ∼2 ∼1000 45 (<0.0001) 83 (<0.0001) 0.93 (0.008)(0.39)f
p21 control 89 69 31.0 N/D 45 (<0.0007) 0.51 (0.69)
p21 mifepristone
A [10 nM]
89 <2 >1000 52 (<0.0001) 69 (<0.0055) 0.77 (0.38)
aEach treatment sample was compared to the relevant control sample using a one-tailed Fisher’s exact test.
bRepeat length distributions in each replicate were compared to the progenitor culture using a one-tailed Mann–Whitney U test. The maximum P-value
obtained across all the replicates for each treatment is shown.
cMedian repeat lengths for each treatment were compared to the relevant control culture using a two-tailed Mann–Whitney U test as previously described
(31).
dChemical cell cycle arrest of cells was performed in two independent experiments, one forMMC, apicidin, TSA andHU treatment, and one for roscovitine
treatment.
eSingle acute exposure.
fCompared relative to the pSwitch mifepristone A control.
maintained in parallel with six un-induced controls (Sup-
plementary Figures S1 and S5). BrdU incorporation levels
(P< 0.0001; Fisher’s exact test) and PCNA expression (P<
0.05;Mann–WhitneyU test) were both greatly reduced, and
cell numbers either increased very slowly with time (p21 ex-
pression) or initially increased slightly and then decreased
with time (p16 expression) (Figure 1A). Although neither
cell line was completely arrested throughout the course of
the experiment, PDTs were increased by ∼40-fold relative
to un-induced controls (Table 1). As with the chemical ap-
proach to cell cycle arrest, the repeat continued to expand
(P< 0.006; Mann–WhitneyU test) in all six replicates from
both p16 and p21 genetically arrested cells at rates at least as
great as those of control cells (P >> 0.05; Mann–Whitney
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Figure 3. The expanded CAG·CTG repeat continues to expand in chemically arrested cells. (A) Representative SP-PCRs of the expanded CAG·CTG repeat
in six replicate D2763Kc2 cell cultures that were chemically arrested for the time period indicated. Also included are the relevant dividing cell controls and
the progenitor culture from which all cultures were derived at day zero. The scale on the right indicates the DNAmolecular weight markers converted into
number of CAG•CTG repeats. (B) Box plots of CAG•CTG repeat length variation in cells under chemical cell cycle arrest. Statistically significant increases
in the median transgenic repeat size between all six replicate cultures and the progenitor culture were detected inmost cases and are indicated above the
corresponding graph panels (*, P < 0.05; Mann-Whitney U test), with the exception of the control cultures collected at day 56. Statistically significant
differences in the median rates of expansion were observed for mitomycin C and hydroxyurea treatments relative to proliferating control cultures, and they
are indicated below the corresponding graph panels (*, P < 0.05; Mann-Whitney U test).
U test) (Table 1, Figure 4). Indeed, the expansion rates of
the induced p16-expressing cells were significantly higher
than p16 un-induced controls (P = 0.008), but were no
greater than inmifepristone-treated, ‘induced’ pSwitch con-
trols (Table 1).
To further discard the possibility of genotoxic effects of
chemical exposure as the major source of repeat expansion
in arrested D2763Kc2 cells, we monitored repeat dynam-
ics in a small number of primary kidney cultures arrested
bymild contact inhibition or serum starvation (Supplemen-
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Figure 4. The CAG·CTG repeat expansion continues to expand in genetically arrested cells. (A) Representative SP-PCRs of the expanded CAG·CTG
repeat in six replicate D2763Kc2 cell cultures that were arrested byp16 or p21 overexpression for the time period indicated. Also included are the relevant
un-induced, proliferating cell culture controls and the progenitor culture from which all cultures were derived at day zero. The scale on the right indicates
the DNA molecular weight markers converted into number of CAG•CTG repeats. (B) Box plots of CAG•CTG repeat length variation in cells under
chemical cell cycle arrest. Statistically significant increases in the median transgenic repeat size between all six replicate cultures and the progenitor culture
were detected in all cases and are indicated above the corresponding graph panels (*, P < 0.05; Mann–Whitney U test).
tary Figure S6). The analysis revealed the continuous accu-
mulation of larger repeat alleles in non-dividing cells in the
absence of chemical treatment or protein overexpression. In
summary, ongoing repeat size gains in cells arrested by over-
expression of negative regulators of cell cycle progression or
by mild contact inhibition and serum starvation provides
additional support for the dissociation between repeat ex-
pansion and cell division.
Cell cycle arrest does not initiate triplet repeat instability
Using both chemical and genetic induction of cell cycle ar-
rest, we have shown that an expanded CAG·CTG repeat
continues to expand in cells arrested at various stages of the
cell cycle including S, G1, G2 and G2/M at rates that are
at least equivalent to those observed in dividing cells. These
data indicate that expansions are not limited to S-phase, ex-
cluding DNA polymerase slippage during replication as the
primary initiating event. Interestingly, the repeat expansion
rate was significantly higher under some conditions of cell
cycle arrest. Combined with the apparent preferential accu-
mulation of CAG·CTG expansions in tissues enriched for
post-mitotic cells in vivo (6,26,30), these data raise the in-
triguing possibility that cell cycle arrest may be an initiat-
ing event in mediating expansions. We tested this hypoth-
esis by using TSA, apicidin and MMC to arrest D2763L
lung cells in which the repeat is normally stably maintained
(32). Cell cycle arrest failed to stimulate repeat expansion
in these cells (Figure 5A). These results also demonstrate
that the continuous accumulation of repeat size variability
in D2763Kc2 cells arrested by chemical exposure cannot be
accounted for by a major genotoxic effect of the drugs used
on DNA metabolism. Likewise, serum starvation induced
cell cycle arrest (Figure 1), but did not destabilize the ex-
panded CAG·CTG repeat tract in three independent Dmt-
D transgenic MEF cell lines (Figure 5B). These data indi-
cate that neither DNA replication nor cell cycle arrest, per
se, are necessary or sufficient to initiate expansion and es-
tablish that the major initiating event for repeat expansion
in these cells is cell cycle-independent. Given the identical
cis context of the expanded CAG·CTG repeat tract in all
the cell lines analyzed, these results predict a major role for
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Figure 5. Cell cycle arrest is not sufficient to mediate CAG·CTG repeat
expansion. Representative SP-PCRs of the expanded CAG·CTG repeat in
chemically arrested D2763L lung cell cultures (A) and MEF cell cultures
arrested by serum starvation (B) are shown. Also included are the relevant
dividing cell controls, the embryo from which the MEF line was estab-
lished, the progenitor culture from which all cultures were derived at day
zero and the vehicle DMSO control. For clarity, only one representative
replicate from each set of six replicate cultures, and data from only one of
the threeMEF cell lines analyzed, is shown.D2763L lung cells were treated
for 90 days with 500 nM apicidin or 100 nM trichostatin A, or for 45 days
with 30 M MMC. The scale on the right indicates the DNA molecular
weight markers converted into number of CAG·CTG repeats.
trans-acting tissue-specific factors independent of cell cycle
dynamics.
DISCUSSION
Here, by monitoring repeat size variability over time in ar-
rested cultures we have demonstrated directly that trinu-
cleotide repeats continue to expand in non-dividing mam-
malian cells. This effect was consistently observed in cells
arrested at different stages of the cell cycle through a variety
of chemical and genetic approaches. These data unequivo-
cally establish that expansions can occur independently of
cell cycle progression and are not limited to S-phase and are
thus not linked to genome duplication. Strikingly, the rates
of expansion observed were similarly high in both dividing
and non-dividing cells. Indeed, only exposure with HU re-
duced the expansion rate relative to dividing cells, and this
was the treatment that had the least effect on progression
through the cell cycle, possibly inducing S phase stasis (43).
The minor BrdU incorporation following other treatments
argues against S phase stasis and significant genomic DNA
duplication in treated cells. MMC, which precipitated a ro-
bust cell cycle arrest, actually resulted in a more than 2-fold
increase in the expansion rate. In all the other treatments,
the rates of expansionwere comparable in dividing and non-
dividing cells. Although these data do not preclude a role
for cell division-dependent replication slippage inmediating
expansions in the dividing cells, the simplest explanation is
that cell division per se has little effect on the rate of repeat
expansion and that the repeat size gains occur in a time-
dependent manner in both the dividing and non-dividing
cells. In vivo support for a cell division-independent expan-
sion mechanism is afforded by several lines of circumstan-
tial evidence, not least of which is the observation of large
expansions in somatic tissues enriched for post-mitotic cells
such as muscle in DM1 patients (26) and brain of HD pa-
tients (6), and in a variety of ostensibly post-mitotic tissues
of transgenic mouse models of unstable CAG·CTG repeats
(27–28,30). More directly, significant repeat gains were ob-
served in apparently terminally differentiated neurons phys-
ically selected from human and mouse HD brains (44,45).
However, the activation of neurogenesis in neurodegenera-
tive disorders (46) confounds the dissociation between cell
division and repeat expansion in HD neurons.
Very interestingly, the integration of data on tissue-
specific somaticmosaicism inHD transgenicmice with high
throughput gene expression data revealed a negative cor-
relation between cell cycle pathways and the degree of re-
peat instability of a tissue (47), consistent with a cell cycle-
independent expansion mechanism. Indeed, these authors
proposed that cell cycle arrest might even promote instabil-
ity and provided some data in support of this idea (47). To
further test this hypothesis we arrested both an established
mouse lung cell line and primary MEFs, in which the exact
same CAG·CTG-containing transgene is stably maintained
during cellular proliferation. The expanded triplet repeat
was not destabilized in these arrested cells, suggesting that
exit from the cell cycle alone is not sufficient to initiate in-
stability. Our data are consistent with in vivo repeat stabil-
ity in regions of the brain, such as the cerebellum, in which
only very low levels of mosaicism are usually observed even
though many of the cells are quiescent (6). These data do
not preclude a role for exit from the cell cycle in modifying
repeat dynamics, but do confirm that the cell cycle is not the
only factor in driving instability and that other trans-acting
factors must also be important in defining the tissue speci-
ficity of expansion.
Most of the support for a replication-dependent mecha-
nism of trinucleotide repeat instability comes frommicroor-
ganisms (21,24–25) and mammalian cell models (10,48,49)
in which the bias toward expansions observed in humans
is not reproduced. The relevance to the repeat dynamics in
humans of observations made in such models remains un-
known. The apparent stabilizing effect of cell cycle arrest
by serum starvation on the expanded repeat in DM1 fibrob-
lasts (11) likely reflects the low rate of expansion observed
in these cells and the insensitive detection methods used.
Similarly, the apparent destabilizing effect of polymerase
inhibitors on human cell lines carrying CAG·CTG repeat
expansions has been interpreted to provide support for a
replication-dependent mutation pathway (10,11). However,
the low doses of polymerase inhibitors used were insuffi-
cient to block cell cycle progression, but did lengthen PDTs.
It is thus possible that the increase in the rate of expansion
per PD was mediated by an indirect effect on cell cycle dy-
namics, and that the rate of expansion per unit of time was
not affected.
While DNA duplication is limited to S-phase, DNA re-
pair occurs at all stages of the cell cycle and is thus a
Nucleic Acids Research, 2014, Vol. 42, No. 11 7055
good candidate to facilitate repeat expansion. Indeed, the
requirement of DNA MMR genes, such as Msh2 (13,16),
Msh3 (12,50) and Pms2 (14) to mediate repeat expansions,
combined with the data presented here, supports an alter-
native mutation mechanism to replication slippage that is
based on inappropriate DNA MMR (14). In this model,
MMR proteins process alternative DNA structures formed
within repeat tracts to generate somatic instability in non-
dividing cells. Consistent with this view, MMR proteins
have recently been shown to scan the genome independently
of their association with replication factories and to initi-
ate a repair reaction (51) or mediate the mutation of sin-
gle bases in non-dividing cells (52). More recently, small
repeat sequences extruded from the conventional B-DNA
helix have been shown to activate MMR in the absence of
DNA replication (53).
Our data do not preclude a role for DNA replication
slippage during cell division in generating repeat size mu-
tations, but raise a pertinent question: what is the relative
contribution of replication-dependent versus cell division-
independent mechanisms in generating expansions in vivo?
Here, we have established that rates of repeat expansion in
arrested cells were at least as high as those in rapidly pro-
liferating cells, showing that DNA replication-independent
pathways are capable of generating high levels of vari-
ation. It seems reasonable to assume that cell division-
independent mechanisms must be operating in vivo to gen-
erate dramatic levels of somatic mosaicism and it is possible
that DNA replication slippage during genome duplication
plays only a minor role.
The data presented here definitively establish that a ma-
jor mechanism exists for expanding trinucleotide repeats in
mammalian cells, independent of the cell cycle. Indeed, by
establishing that neither cell progression or cell cycle ar-
rest are either necessary or sufficient to initiate instability,
we further highlight the pivotal role of MMR and other
DNA repair genes (e.g. Ogg1 (17) and Xpa (18)) and other
cis-acting factors in driving tissue-specific repeat instabil-
ity. New insights into the expansion pathway will provide a
rational basis for the development of novel therapies based
on suppressing somatic expansion (2). The search for chem-
ical modifiers of trinucleotide repeat dynamics in culture is
complicated by the requirement for relatively long period of
culture to reliably detect changes in the rate of repeat expan-
sion. Long culture periods of rapidly dividing cells intro-
duce the opportunity for stochastic variation and cell selec-
tion effects, confounding the interpretation of results. The
arrested cell cultures developed here may circumvent this
pitfall, reducing the selection biases. Moreover, this non-
proliferative model reflects to a certain extent the cellular
dynamics of the post-mitotic tissues primarily affected in
the repeat expansion disorders and the primary targets for
therapeutic intervention. Therefore, it provides a useful cell
model to identify factors and therapeutic agents capable of
modifying the dynamics of expanded CAG·CTG repeats in
post-mitotic tissues.
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